1-2 of 2
Aitomi Bittner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Treatment Additions Ibrutinib + Bortezomib + R-CHOP for Higher-Risk DLBCL: Efficacy, Feasibility and Molecular Signatures for Future Treatment Decisions

Sophy Denker, Aitomi Bittner, Julia Kase, Mareike Frick, Jörg Hoffmann, Corinna Trenker, Ulrich Keller, Christian Bogner, Andreas Hüttmann, Jan Dürig, Martin Janz, Stephan Mathas, Reinhard Marks, Ulrike Krohn, Il-Kang Na, Paulina Richter-Pechanska, Animesh Bhattacharya, Bernhard Gebauer, Lynn Savic, Norbert Hübner, Altuna Akalin, Roland Eils, Lars Bullinger, Clemens Schmitt
Journal: Blood
Blood (2024) 144 (Supplement 1): 6188.
https://doi.org/10.1182/blood-2024-207123
Published: 2024
Journal Articles

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Jing Du, Martin Neuenschwander, Yong Yu, J. Henry M. Däbritz, Nina-Rosa Neuendorff, Kolja Schleich, Aitomi Bittner, Maja Milanovic, Gregor Beuster, Silke Radetzki, Edgar Specker, Maurice Reimann, Frank Rosenbauer, Stephan Mathas, Philipp Lohneis, Michael Hummel, Bernd Dörken, Jens Peter von Kries, Soyoung Lee, Clemens A. Schmitt
Journal: Blood
Blood (2017) 129 (1): 71–81.
https://doi.org/10.1182/blood-2016-02-700773
Published: 2017
Includes: Supplemental data